BusinessWeek Logo
November 23, 2009 6:34 PM ET

BioTech Medics, Inc.

(BMCS:OTC)

Market Cap
3.7M
Total Revenue
476.8K
EBITDA
--
DILUTED EPS TTM
--
P/E
--
P/S
--
Return On Asset
--
Return On Equity
--
K = Thousands  M = Millions  B = Billions

BMCS Details

BioTech Medics, Inc. engages in the manufacture and sale of medical laser devices for the treatment of various symptoms and physical ailments of the human body associated with pain in the United States. It also trains and certifies medical professionals in the use of its laser devices; and manages pain management and wellness medical centers in the United States. The company also developed the patented SHBAN solution, a non-alcohol based antimicrobial product. In addition, it sells BioBody Products containing liquid vitamins and minerals, and other ingredients. Further, the company distributes the NeuroLase 150C medical laser devices in Colorado Springs, Colorado. It was formerly known as Corbel Holdings, Inc. and changed its name to BioTech Medics, Inc. in November 2004. The company was incorporated in 1997 and is headquartered in Irving, Texas.

BMCS Top Compensated Officers

People Page No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

Key developments for BioTech Medics, Inc. (BMCS)

BioTech Medics Receives Independent Clinical Testing Results of SHBAN Hand Sanitizer Solution

BioTech Medics, Inc. has received independent clinical testing results of its SHBAN(TM) Hand Sanitizer Solution to prove SHBAN(TM) kills the H1N1 (Swine) Influenza A virus. An ATS Lab Study proves that SHBAN Antiseptic Hand Sanitizer caused a 96% reduction (killing) of the H1N1 virus titer using an ex-vivo skin model test method. The SHBAN Antiseptic has had other independent clinical tests which demonstrated the SHBAN ability to continue to kill virus titer, germs, fungus, mold, mildew and bacteria over various testing periods from 10 seconds to 4 hours. This study and a half dozen other studies confirms the long-lasting effectiveness of SHBAN in reducing germs, bacteria and viruses. Alcohol gel hand sanitizers only kill germs while wet about 12 to 15 seconds. SHBAN has also been independently clinically tested to prove SHBAN is non-toxic (causing no dermatitis on human skin). BioTech recently announced foreign distribution agreements in Turkey, Dubai and Brazil (pending). Additional distribution negotiations are in progress for Qatar, Greece, Mexico, Central America and Thailand. BioTech Medics estimates 2010 SHBAN worldwide sales at $50 million. USA distribution agreements are also pending.

BioTech Medics Inc. Enters into Wholesaler Distribution Agreement with Dubai Distributor

BioTech Medics Inc. announced that they have entered into a wholesaler Distribution Agreement for BioTech's patented and exclusive SHBAN Antimicrobial Hand Sanitizer Products with a Dubai distributor. The initial income and fees to BioTech for 2009 for the Dubai Distributorship is $58,800 and projected $2,000,000 in sales for 2010.

BioTech Medics Announces Preliminary SHBAN Antiviral Solution H1N1 (Swine) Influenza A Testing Results

BioTech Medics Inc. announced that it has received preliminary independent clinical testing of its patented SHBAN(TM) Hand Sanitizer Solution to demonstrate it kills the H1N1 (Swine) Influenza A virus. Preliminary lab results indicated that SHBAN Hand Sanitizer Solution at three different concentrates caused a reduction (killing) of the H1N1 virus titer within one (1) minute. The SHBAN Solution continued to work and increased the kill of the H1N1 virus titer over a testing period of 30 minutes. This study confirmed the long-lasting effectiveness of SHBAN Solution in reducing germs, bacteria and viruses. Additional studies are being conducted. Significantly, SHBAN has also been independently clinically tested to prove SHBAN is non-toxic (causing no dermatitis on human skin).

Stock Quotes

Company Lookup

BMCS Competitors

Company Last Change
No competitor information is available for BMCS.
View Industry Companies
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation BMCS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.8x

BMCS

BMCS transactions

Type
Date
Target
No transactions in the last 6 months.

Companies Toolbox

Company Tools
Investing Tools



Close Recommend A Data Enhancement Or Correction

For BioTech Medics, Inc. (BMCS) Snapshot

Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.

Required Information Missing - Please enter your information in the following field(s):
DATA TO BE REVIEWED
Page Section*

Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.

Data Point*

Please indicate which data is in error.

CONTACT INFORMATION

Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.

Your Name*
Your E-Mail Address*
YOUR RECOMMENDATION

Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.

Cancel Submit
You can drag this form within your browser window.

Thank you for submitting your information. We investigate data update requests and error reports as quickly as possible. Since some are easier to investigate than others, please be patient as we perform our research; it could take several weeks, depending on the nature of the error and whether your company is public or private.

You can drag this form within your browser window.